Alternative Funding Task Force; create from members of the Mississippi Rare Disease Advisory Council.

SB 2756 creates a task force from the Mississippi Rare Disease Advisory Council to study how alternative funding programs - such as insurance company discount initiatives - affect patients' access to affordable prescription drugs. The task force will examine these programs' history, business models, and impacts on patient assistance programs and coverage options across Mississippi and the U.S. It must complete its study by December 1, 2025, and submit findings with legislative recommendations to state officials and committees. The goal is to assess whether expanding such programs could improve medication access for patients with rare diseases and other conditions.